49 results about "Therapy management" patented technology

A system and method for prescription therapy management and compliance are provided. The system framework integrates primary databases from pharmacies, pharmacy benefit managers (PBMs), health plans, and EHR providers with a secondary database system, user interface, and wireless messaging platform, in order to extract and aggregate user-specific prescription data and make it available to users through a personalized account and as a part of a wireless prescription reminder service. The system helps users access, aggregate, manage, update, automate, and schedule the prescriptions they are currently taking. Users receive real-time wireless prescription dosing reminders based on their prescribed drug, dosage, and other indications, tailored to each individual's daily schedule. These wireless dosing reminders (i) include additional instructional content such as pill images, compliance tools, and Web or WAP drug links, (ii) are automatically scheduled and transmitted based on the user's prescription source data, in conjunction with selections indicated on their personal account, and (iii) are transmitted via SMS, EMS, MMS, WAP, email, and other formats to the user's mobile phone, PDA, or other wireless device. The integrated interface and secondary database system enable a number of additional system features which focus on compliance and management of the underlying source prescription data.

An method and system that allows a patient to access stored preset patient therapy programs, that are resident in a medical device such an implantable pump or a combination medical device having an implantable pump and a implantable neural stimulator, and to create personalized therapy programs or automatic timing therapy programs from preset therapy programs to accommodate the patient's particular activity. Alternatively, the patient can select and access stored preset patient therapy programs and combine at least two modified or unmodified preset therapy programs to create personalized therapy programs.

Method and system for providing diabetes management and insulin therapy based on substantially real time glucose monitoring system is provided.

A method of diabetes analysis includes receiving a plurality of glucose level readings for a user. A common event occurrence in at least two of the glucose level readings is determined. The at least two glucose level readings from the common event occurrence onwards in time for a time period is analyzed. A glucose level pattern formed by the at least two glucose level readings having a similar shape is determined. At least one anomalous glucose level reading having the similar shape and not conforming to the glucose level pattern is analyzed. The at least one anomalous glucose level reading is adapted to the pattern to form an adapted glucose level pattern. An insulin dosage for the time period beginning at the common event occurrence is calculated based on the adapted glucose level pattern.

A method is provided that includes initiating adjudication of a primary claim in response to a purchase transaction at a primary payer for a client at a point of sale of a healthcare provider, and adjudicating one or more services of a program of the administrator to which the client is enrolled and / or one or more secondary benefits following the adjudication of the primary claim. The purchase transaction is applicable to the respective program and the respective secondary benefit, and the program includes one or more services. The method also includes providing the one or more services and / or secondary benefits to the client in response to adjudicating the one or more services and / or secondary benefits.

A system and method for prescription therapy management and compliance are provided. The system framework integrates primary databases from pharmacies, pharmacy benefit managers (PBMs), health plans, and EHR providers with a secondary database system, user interface, and wireless messaging platform, in order to extract and aggregate user-specific prescription data and make it available to users through a personalized account and as a part of a wireless prescription reminder service. The system helps users access, aggregate, manage, update, automate, and schedule the prescriptions they are currently taking. Users receive real-time wireless prescription dosing reminders based on their prescribed drug, dosage, and other indications, tailored to each individual's daily schedule. These wireless dosing reminders (i) include additional instructional content such as pill images, compliance tools, and Web or WAP drug links, (ii) are automatically scheduled and transmitted based on the user's prescription source data, in conjunction with selections indicated on their personal account, and (iii) are transmitted via SMS, EMS, MMS, WAP, email, and other formats to the user's mobile phone, PDA, or other wireless device. The integrated interface and secondary database system enable a number of additional system features which focus on compliance and management of the underlying source prescription data.

Surgical monitoring techniques detect surgical contexts, such as induction, intubation, preparation and positioning, incision, maintenance, emergence, recovery, and / or therapy administration based on information received from a patient monitor and / or other medical equipment, which can be compared to predetermined data patterns, which can be based on heuristic or statistical classifications. With detectors and / or controllers operating in conjunction therewith and in various combinations thereof, responses can also be invoked and / or also overridden.

A method of providing therapy management development includes providing a therapy management development platform having a plurality of levels of functionality, the platform including a medical device capable of providing therapy management, setting the platform to a first level of access to the functionality relative to the medical device, and modifying the operation of the medical device using the platform. The method also includes receiving an indication of approval to change the level of access to the functionality of the platform to a second level of access, and setting the platform to the second level of access to the functionality of the platform in response to receipt of the indication of approval. The platform is also provided.

The present invention is directed to methods and compositions for inducing, promoting or otherwise facilitating pain relief. More particularly the present invention discloses the combination of a nitric oxide donor and an opioid analgesic in the therapeutic management of vertebrate animals including humans, for the prevention or alleviation of pain, particularly moderate to severe pain. In particular, the nitric oxide donor is a slow-release nitric oxide donor or is formulated to provide a sustained release of a low dose of nitric oxide.

A system and method for providing closely-followed cardiac therapy management through automated patient care is presented. A patient under remote care is enrolled in a monitoring program following commencement of a cardiac therapy regimen to be undertaken by the patient. A wearable monitor, including one or more patient physiology sensors and a wireless interface providing enabling bi-directional data exchange, is provided to the patient. Patient physiometry, including quantitative physiological measures, is periodically collected from the wearable monitor over the wireless interface concomitant to performance of the cardiac therapy regimen. The patient physiometry is evaluated to determine a trend indicating an onset, progression, regression, absence of, and status quo of patient health status.

This invention relates to a method and system for improving diagnostic imaging and / or delivering therapeutically active agents for control of hyperlipidemia and infectious diseases (bacterial or viral), comprising nanoscale block copolymer assemblies carrying drug molecules in its core and receptor peptide in the corona surrounding the core, forming larger micelle or vesicle aggregates with target molecules such as LDL molecules and surface lipid of microorganisms.

An inhalation therapy device includes a supply element for a gaseous medium, for example ventilation air of a ventilation device, and a flow influencing element, by means of which a sheath flow is formed around an expansion area for an aerosol generated by an aerosol generator for therapeutic administration. Deposition of aerosol droplets or particles on the inner way of the housing of the inhalation therapy device is effectively prevented in this manner.

Methods and Systems implement patient management. In some cases, a patient management system 200 may include one or more respiratory pressure therapy devices to deliver respiratory pressure therapy to patients, and generate therapy data relating to a therapy session for a patient. The patient management system may include a data server communicating with the therapy device(s). The data server may compute, from therapy data, therapy summary data for the session, the summary data may include one or more statistics summarising therapy data. The patient management system may include a therapy management server communicating with the data server. The therapy management server may apply one or more rules to the summary data, update or generate one or more workflow groups of patients, each workflow group corresponding to a rule, depending on results of the respective rule applications; and / or serve a graphical layout representing one or more workflow groups.

The invention discloses a rehabilitation therapy management system which comprises a rehabilitation therapy server unit, a rehabilitation therapy evaluating and diagnosing workstation unit, a rehabilitation equipment unit, a communication unit and a power supply unit; the rehabilitation therapy server unit, the communication unit, the rehabilitation therapy evaluating and diagnosing workstation unit and the rehabilitation equipment unit are connected in sequence; the power supply unit is respectively connected with electric equipment in the rehabilitation therapy server unit, the communication unit, the rehabilitation therapy evaluating and diagnosing workstation unit and the rehabilitation equipment unit. According to the rehabilitation therapy management system disclosed by the invention, the disadvantages of low working efficiency, fussy therapy process, waste of rehabilitation resource, poor reliability, small application range and the like in the prior art can be overcome; the advantages of high working efficiency, convenience in therapy, shared resource, good reliability and large application range can be realized.

A computer implemented method and system for tracking and managing therapy sessions using a therapy management application (TMA) is provided. The TMA is accessible by an electronic device in multiple access modes. The TMA schedules therapy sessions with multiple clients and generates one or more goals for each of the clients based on an evaluation of the clients in the therapy sessions. The TMA categorizes the generated goals for each of the clients into one or more goal categories and defines one or more goal measurements for each of the generated goals within each of the goal categories. The TMA collects and tracks data acquired from the scheduled therapy sessions of each of the clients for the defined goal measurements via a graphical user interface. The TMA generates progress reports based on performance of each of the clients for each of the generated goals using the collected and tracked data.

A device and a method for preventive treatment of evolving pulmonary edema in patients which are at risk of complication associated with pulmonary edema which is based on the monitoring of internal thoracic impedance of the patient. The device extracts the internal thoracic impedance from measured trans-thoracic impedance and is relatively immune to variations in skin / electrode interface impedance. The method includes identification of a stage of interstitial edema development before the appearance of a clinical indication and the beginning of an appropriate medicinal treatment in accordance to variations of the monitored internal thoracic impedance. The method also indicates the appropriate moment for terminating the medicinal treatment and can be applied when the patient and his treating physician are positioned at remote locations.

A method for managing the treatment regimen of a human patient using an over-the-counter (OTC) medicine is provided. The method comprises providing to the patient an interactive therapy managing system for de-selecting himself from the treatment regimen. The interactive therapy managing system may comprise, for example, an in person contact, or an electronically enabled element, such as an automated voice response system, a text-messaging system, an email system, a touch-tone telephone menu system, and a website.

Methods of treating, managing or preventing exercise-induced asthma are disclosed. Specific methods encompass the administration of (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione alone or in combination with a second active agent. Pharmaceutical compositions and single unit dosage forms are also disclosed.

The present invention provides a system and method for estimating a blood flow waveform contour from a pressure signal. An arterial or ventricular pressure signal is acquired from a pressure sensor. Landmark points are identified on the pressure waveform that correspond to features of a flow waveform. In one embodiment, the landmark pressure waveform points correspond to the onset of flow, the peak flow, and the end of the systolic ejection phase. The landmark pressure waveform points define a contour that approximates the flow contour. Beat-by-beat flow contour estimation can be performed to allow computation of flow-related hemodynamic parameters such as stroke volume or cardiac output for use in patient monitoring and / or therapy management.

The invention discloses a combined genome for evaluating prognosis of clear cell renal cell carcinoma (ccRCC) and application of the combined genome, relates to the technical field of medical biological detection, and provides novel application of the combined genome of ADAMTS9, C1S, DPYSL3, H2AFX, MINA, PLOD2, RUNX1, SLC19A1, TPX2 and TRIB3, particularly application in preparation of a ccRCC prognosis evaluation reagent or kit. The genome is derived from a molecular marker significantly correlated with a ccRCC metastasis way, and the discovery of the genome model provides a new strategy for predicting the ccRCC recurrent risk and the long-term survival condition of a patient after operation, plays important roles in judging the prognosis of the ccRCC patient, can evaluate the risk level of tumor progression or death of the patient after ccRCC operation, contributes to guiding a clinician to perform an individualized precise therapeutic strategy, can increase the postoperative survivalrate of the patient, and has important guide significance postoperative follow-up monitoring and sequential therapy management of the ccRCC patient.

A remote medical assessment and therapy management apparatus comprising a center user interface, a center computer coupleable with the center user interface. The center computer displays information via the center user interface for use in developing a therapeutic prescription and receives therapeutic control inputs from a user. A remote device includes a medical diagnostic instrument for acquiring biophysical data from a patient, a medical therapeutic instrument that provides a therapy to the patient, and a remote computer that receives diagnostic signals from the diagnostic instrument and transmits therapeutic control signals to the therapeutic instrument. A network interface is connected between the first center computer and the remote computer and transmits diagnostic signals from the remote computer to the center computer and control signals from the center computer to the therapeutic instrument via the remote computer.

The invention provides a cancer patient nutrition management system, and relates to the technical field of cancer nutrition therapies. The system comprises a patient basic information module, a grouping information module, a nutrition evaluation module, a medicine therapy monitoring module, a patient follow-up visit module and a therapy management log module. The system automatically marks patients in a grading mode, and rapid grouping is achieved; a pharmacist carries out nutrition evaluation on the patient every day, and an improved PG-SGA method is adopted for subjective overall evaluationof the patient; and the system records comprehensively-generated nutrition prescription recommendation suggestions according to nutrition evaluation, the nutrition prescription recommendation suggestions are adjusted by pharmacists and then pushed to doctors for checking, and nutrition recommendation prescriptions are obtained after checking of the doctors. The system provided by the invention cansimultaneously realize the functions of automatic grading marking of cancer nutrition treatment patients, online nutrition evaluation, linked checking of nutrition prescriptions by doctors and pharmacists, online communication, regular follow-up visit tables, past treatment file storage and retrieval and the like, saves a lot of time for medical workers, and improves the working efficiency.